检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王雪刚[1] 王战会[1] 马世武[1] 梁敏锋[1] 周彬[1] 侯金林[1]
机构地区:[1]广州南方医科大学南方医院感染内科,510515
出 处:《肝脏》2007年第2期95-98,共4页Chinese Hepatology
基 金:国家自然科学基金(30500434)
摘 要:目的探讨乙型肝炎病毒(HBV)基因型及亚型与YMDD变异的关系,以及前C基因区终止密码变异(A1896)、基本核心启动子(BCP)区T1762/A1764变异在Ba、C1和C2三种基因亚型中的发生情况。方法采用聚合酶链反应-限制性片断长度多态性(PCR-RFLP)法对211例服用拉米夫定后发生YMDD耐药变异的患者HBV进行基因型、基因亚型、A1896及T1762/A1764变异检测。结果211份标本中B基因型占50.7%(107/211),C基因型占49.3%(104/211),与广东地区对照人群HBV基因型分布情况相比无统计学差异(χ2=0.508,P=0.476)。进一步亚型分析发现,107份B基因型全部为Ba亚型;C基因型有C1和C2两种亚型,其中C1亚型占64.4%(67/104),C2亚型占35.6%(37/104),与广东地区对照人群C基因亚型分布情况相比也无统计学差异(χ2=0.043,P=0.836)。A1896变异在Ba亚型中的分布最高(41/107,38.3%),C2亚型次之(13/39,33.3%),C1亚型最低(9/65,13.8%),变异在不同基因亚型中的分布有统计学差异(χ2=11.839,P=0.03)。T1762/A1764变异在C1亚型中的分布最高(34/65,52.3%),C2亚型次之(17/39,43.6%),Ba亚型最低(23/107,21.5%),T1762/A1764变异在不同基因亚型中的分布有统计学差异(χ2=18.384,P<0.001)。结论HBV基因型及亚型并不影响YMDD变异的发生,但3种基因亚型发生A1896及T1762/A1764变异的模式存在明显不同。Objective To investigate the relationship between hepatitis B virus (HBV) genotypes/subgenotypes and the development of YMDD mutation, as well as pre-core stop code (A1896) and basic core promoter (BCP/ T1762/A1764) mutations in Chinese patients with chronic hepatitis B. Methods HBV genotypes, subgenotypes, A1896 and T1762/A1764 mutations were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in 211 chronic HBV carriers with YMDD mutant strain after receiving the treatment of lamivudine. Results In 211 patients, 107 genotype B (50.7%), 104 genotype C (49.3%) were identified, respectively. No statistical difference was found when compared with the distribution of HBV genotypes in Guangdong province (χ^2 = 0. 508; P = 0. 476). Further analysis showed all genotype B belong to subgenotype Ba, 67 with C1 subgenotype (67/104, 64.4% ) and 37 with C2 subgenotype (37/104, 35.6% ). No significant difference was found compared with the distribution of C1/C2 in Guangdong (χ^2 = 0.043; P = 0.836). Prevalence of A1896 was significantly higher in patients with Ba (41/107, 68.3%) than C2 (13/19, 33.3%) and C1 subgenotype (9/65, 13.8%) (χ^2 = 11.839, P =0.03). Development of T1762/A1764 mutations was significantly higher in C1 (34/65,52.3 % ) than C2 ( 17/39, 43.6% ) and Ba subgenotype (23/107, 21.5 % ) (χ^2 = 18.384;P 〈 0.00l). Conclusion There was no significant difference in development of YMDD mutation in different genotypes and subgenotypes of HBV in Guangdong provine. But the prevalence of A1896 and T1 762/A1 764 mutations was significantly different in genotypes and subgenotypes of HBV in Chinese patients with chronic hepatitis B.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.229